Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It

Mantle cell lymphoma (MCL) is a relatively rare

Next up in the Leukemia & Lymphoma Society's free telephone/web education programs

Biovest International, makers of the personalized therapeutic lymphoma vaccine BiovaxID, have

The European Commission approved the drug Velcade (bortezomib) for the treatment of

Mantle cell lymphoma remains one of the more elusive subtypes of

According to an open-label multicenter, phase 2 study coming from the US and Europe, the

A new study in the New England Journal of Medicine points towards a more tolerable

Because science has only recently became familiar with mantle cell lymphoma, there aer not

Mantle cell lymphoma (MCL), a rare disease that has been difficult to study in clinical

Mantle cell lymphoma (MCL) is a very rare and difficult to

On June 5, the U.S. Food and Drug Administration notified Celgene corporation that the

Among the many fairly commonly mentioned subtypes of non-Hodgkin